Results 171 to 180 of about 45,681 (215)

The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Drusin SI, Nordmann P, Pitout J, Peirano G, Vila AJ, Moreno DM, Poirel L.   +7 more
europepmc   +1 more source

Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Winkler ML, Papp-Wallace KM, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales. [PDF]

Future Microbiol
Bhowmick T, Canton R, Pea F, Quevedo J, Santerre Henriksen A, Timsit JF, Kaye KS.   +6 more
europepmc   +1 more source

Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant K. pneumoniae Isolates? [PDF]

Pathogens
Ceylan AN, Kömeç S, Şanlı K, Öncel B, Durmuş MA, Gülmez A.   +5 more
europepmc   +1 more source

β-Lactam/β-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing <i>Enterobacteriaceae</i> Bloodstream Infections: An Underestimated Clinical Entity. [PDF]

Infect Drug Resist
Zhang Y, Ni S, Hu H, Zhang S, Feng H, Ni L, Chen H, Yang Q, Yu M, Qu T.   +9 more
europepmc   +1 more source

Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Kimbrough JH, Winkler ML, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. [PDF]

Microbiol Spectr
Kim TY, Baek JY, Suh E, Lee J-K, Yu H-J, Ko J-H, Huh HJ, Lee NY.   +7 more
europepmc   +1 more source

Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR <i>Acinetobacter baumannii</i>. [PDF]

J Microbiol Biotechnol
Al-Lawati H, Al-Raisi F, Elfaky MA, Abdel-Halim MS, Abbas HA, Mansour B, Hegazy WAH, Seleem NM.   +7 more
europepmc   +1 more source

Metabolomic Profile Modification in the Cerebellum of Mice Repeatedly Exposed to Khat and Treated with β-Lactamase Inhibitor, Clavulanic Acid. [PDF]

Metabolites
Alanezi AA.
europepmc   +1 more source